The Neuroscience of Being Human
The Neuroscience of Anhedonia
Why depression steals pleasure before it steals hope, how the brain's reward circuitry shuts down under chronic stress, and what it means when the things you used to love stop meaning anything at all
1,300-word article with 8 Harvard references.
Key takeaways
- Anhedonia is not the same as sadness. It is the collapse of the brain's reward system, the circuitry that generates the experience of wanting, anticipating, pursuing, and enjoying. A person with anhedonia can be surrounded by everything that once brought them joy and feel nothing. The music sounds the same. The food tastes the same. But the neural signal that once said this matters has gone silent (Treadway and Zald, 2011).
- Kent Berridge's work at the University of Michigan established that pleasure has two neurologically distinct components: wanting (incentive salience, driven by dopamine) and liking (hedonic impact, driven by the opioid and endocannabinoid systems). Anhedonia can affect one or both. Most commonly in depression, it is the wanting system that fails first: the person can still experience a momentary flicker of pleasure if exposed to a reward, but they have lost the motivation to pursue it (Berridge and Robinson, 2016).
- The ventral striatum, particularly the nucleus accumbens, shows reduced activation in response to rewarding stimuli in people with anhedonia. Functional imaging studies consistently find that the brains of anhedonic individuals respond less to anticipated rewards and show blunted dopamine release compared with healthy controls (Pizzagalli, 2014).
- Chronic stress and sustained cortisol exposure are the primary drivers of anhedonia at the neurobiological level. Glucocorticoids reduce dopamine receptor expression in the ventral striatum, impair the function of the ventral tegmental area, and downregulate the opioid receptors responsible for hedonic experience. The result is a reward system that has been chemically muted by the brain's own stress response.
- Anhedonia predicts treatment resistance. Patients whose depression is dominated by anhedonia respond less well to SSRIs, which primarily target the serotonin system, than to interventions that address the dopamine and glutamate systems. Behavioural activation, exercise, and in some cases dopaminergic agents or ketamine show more promise for this specific symptom profile.
The difference between wanting and liking
Kent Berridge spent decades at the University of Michigan dissecting the neuroscience of pleasure, and his most important finding was that pleasure is not one thing. It is at least two. Wanting is the motivational component: the drive to pursue a reward, the anticipatory pull that makes you reach for the chocolate, plan the holiday, or look forward to seeing someone you love. Liking is the consummatory component: the moment of enjoyment when the reward arrives, the actual hedonic experience. Wanting runs primarily on dopamine, released by neurons in the ventral tegmental area that project to the nucleus accumbens and the prefrontal cortex. Liking runs on a separate system, primarily the mu-opioid and endocannabinoid receptors in tiny hedonic hotspots within the nucleus accumbens and the ventral pallidum (Berridge and Robinson, 2016).
This distinction matters enormously for understanding anhedonia. In most cases of depression-related anhedonia, what collapses first is not the capacity to experience a moment of pleasure when it arrives unbidden, but the drive to pursue pleasure in the first place. The person can still taste the cake and acknowledge that it tastes good. What they have lost is the impulse to bake it, to buy it, to walk to the shop, to get out of bed. The wanting system has shut down, and without wanting, liking becomes irrelevant because the person never gets close enough to the reward to experience it.
The ventral striatum goes quiet
Diego Pizzagalli at Harvard used functional MRI and computational modelling to examine reward processing in people with major depression. He found consistent hypoactivation of the ventral striatum, the region that includes the nucleus accumbens, in response to both anticipated and received rewards. The brains of depressed individuals with anhedonia showed a blunted response to monetary gains, social approval, and pleasurable images. The signal that should have said this is good was attenuated, and the signal that should have driven reward-seeking behaviour was diminished or absent (Pizzagalli, 2014).
The implications extend beyond the subjective experience of pleasure. The ventral striatum is part of the brain's learning system. It encodes prediction errors, the difference between expected and actual outcomes, which are the basis of reinforcement learning. When this system is hypoactive, the person not only fails to enjoy rewards but fails to learn from them. The brain does not update its models in response to positive experiences. Good things happen and leave no trace. This is why a depressed person can have a genuinely pleasant experience, a kind conversation, a beautiful day, and report afterwards that nothing good ever happens to them. It is not that they are lying or exaggerating. Their reward-learning system is not registering the positive data.
How stress dismantles the reward circuit
The question of how anhedonia develops has a straightforward answer at the neurobiological level: chronic stress. Sustained activation of the hypothalamic-pituitary-adrenal axis produces prolonged cortisol elevation, and cortisol has direct effects on the dopamine system. It reduces dopamine receptor density in the ventral striatum, impairs dopamine synthesis in the ventral tegmental area, and alters the firing patterns of dopaminergic neurons from tonic (steady, background) to phasic-only (responding only to intense stimuli). The reward system does not break suddenly. It erodes. Pleasures that once registered begin to require more intensity to produce the same signal. Activities that once felt meaningful begin to feel empty. The person does not notice the change at first because each day is only marginally different from the one before. By the time they realise that nothing brings them joy, the process has been under way for months (Pizzagalli, 2014).
The opioid system takes damage too. Chronic stress downregulates mu-opioid receptors in the hedonic hotspots that Berridge identified, reducing the brain's capacity for consummatory pleasure. And the endocannabinoid system, which modulates both reward and stress responses, becomes depleted under sustained cortisol exposure. The result is a triple assault on the brain's capacity for pleasure: wanting, liking, and the learning that connects behaviour to reward are all simultaneously impaired.
Why anhedonia resists standard treatment
SSRIs target the serotonin system, but anhedonia is primarily a disorder of the dopamine and opioid systems. This mismatch helps explain why anhedonia is one of the symptoms most resistant to conventional antidepressant treatment. Some patients report that SSRIs relieve their sadness and anxiety while leaving their anhedonia untouched or even worsening it, a phenomenon known as SSRI-induced emotional blunting. The drug addresses one aspect of depression while inadvertently suppressing the emotional range that includes positive affect (Nutt et al., 2007).
Interventions that target the dopamine system directly, whether through behavioural activation, physical exercise, or pharmacological agents such as bupropion, show more promise for anhedonia specifically. Behavioural activation works not by making the person feel better first but by reintroducing reward-relevant behaviour despite the absence of motivation, allowing the dopamine system to relearn reward associations through exposure. Exercise increases dopamine receptor expression and promotes the release of endorphins, directly addressing the neurotransmitter systems that anhedonia has compromised. The approach is not to wait until pleasure returns before re-engaging with life. It is to re-engage with life so that the neural systems responsible for pleasure have something to work with.
Invitation to reflect
If you recognise this experience, if the world has gone flat and the things that used to matter have stopped mattering, know that what you are experiencing has a biological basis. Your brain's reward system has been altered by stress, and the absence of pleasure is not evidence that pleasure is gone forever. It is evidence that the system needs repair, and repair is possible.
The hardest part of anhedonia is that it removes the very motivation that recovery requires. You cannot want to get better when the wanting system is offline. This is where external structure, professional support, and the small, deliberate actions of behavioural activation become essential. You do not need to feel like doing something for it to begin rebuilding the circuit. You just need to do it.
References
- Treadway, MT and Zald, DH (2011) Reconsidering anhedonia in depression: lessons from translational neuroscience. Neuroscience and Biobehavioral Reviews, 35(3), pp. 537–555.
- Berridge, KC and Robinson, TE (2016) Liking, wanting, and the incentive-salience theory of addiction. American Psychologist, 71(8), pp. 670–679.
- Pizzagalli, DA (2014) Depression, stress, and anhedonia: toward a synthesis and integrated model. Annual Review of Clinical Psychology, 10, pp. 393–423.
- Nutt, DJ, Demyttenaere, K, Janka, Z, Aarre, T, Bourin, M, Canonico, PL, Carrasco, JL and Stahl, S (2007) The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. Journal of Psychopharmacology, 21(5), pp. 461–471.
- Der-Avakian, A and Markou, A (2012) The neurobiology of anhedonia and other reward-related deficits. Trends in Neurosciences, 35(1), pp. 68–77.
- Rizvi, SJ, Pizzagalli, DA, Sproule, BA and Kennedy, SH (2016) Assessing anhedonia in depression: potentials and pitfalls. Neuroscience and Biobehavioral Reviews, 65, pp. 21–35.
- Whitton, AE, Treadway, MT and Pizzagalli, DA (2015) Reward processing dysfunction in major depression, bipolar disorder and schizophrenia. Current Opinion in Psychiatry, 28(1), pp. 7–12.
- Husain, M and Roiser, JP (2018) Neuroscience of apathy and anhedonia: a transdiagnostic approach. Nature Reviews Neuroscience, 19(10), pp. 655–671.
About the author
Gareth Strangemore-Jones, MHFA, DCST, PDPCP, HPD, DSFH, DMH, AHD, NCTJ, MSC-CPA, PGCE (FE) I & II
MNCPS (Reg.), MNCH (Reg.), MCNHC (Reg.), MAfSFH (Assoc.)
PSA (Acc.), FSE (Fellow), IFfS (Assoc.)
Mental Health First Aider, Pluralistic Counsellor, Clinical Psychotherapist. Consultant Medical Hypnotherapist, Mindfulness Teacher. PGCE-Trained Teacher, Lecturer, Corporate Trainer, Workplace Wellbeing Consultant. PR & Marketing Consultant, Psychology & Behaviour Advisor. Author, Journalist, Broadcaster. Advocate for Mental Health, People & Planet
Founder, CEO & Clinical Lead, The Brain Gym & Research Ltd. Gold standard human therapy, intelligently delivered